Profil
Kevin P.
Baker worked as an Associate Director of Protein Therapeutics at Human Genome Sciences, Inc. and as a Scientist at Genentech, Inc. He then worked at Five Prime Therapeutics, Inc. for a total of 12 years, where he held the position of Vice President of Preclinical Development from 2006 to 2015 and Senior Vice President of Development Sciences from 2016 to 2018.
He also worked as a Senior Vice President of Preclinical Development at Astellas Gene Therapies, Inc. Dr. Baker received his undergraduate degree from the University of Salford and his doctorate from the University of Dundee.
Ehemalige bekannte Positionen von Kevin P. Baker
| Unternehmen | Position | Ende |
|---|---|---|
| FIVE PRIME THERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2018 |
| FIVE PRIME THERAPEUTICS, INC. | Corporate Officer/Principal | 01.07.2015 |
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Corporate Officer/Principal | - |
Ausbildung von Kevin P. Baker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Provides pharmaceutical and diagnostic products | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
University of Salford
University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University Of Dundee
University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
















